| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 蔓荆子黄素; Vitexicarpin | CFN98172 | 479-91-4 | C19H18O8 = 374.34 | 20mg | QQ客服：2056216494 |
| 5-羟基-7,3',4'-三甲氧基黄酮; 5-Hydroxy-3',4',7-trimethoxyflavone | CFN98361 | 29080-58-8 | C18H16O6 = 328.3 | 20mg | QQ客服：1457312923 |
| (S)-5-羟基-7,4'-二甲氧基黄烷酮; 4',7-Di-O-methylnaringenin | CFN98364 | 29424-96-2 | C17H16O5 = 300.3 | 20mg | QQ客服：1413575084 |
| 樱花亭; Sakuranetin | CFN98366 | 2957-21-3 | C16H14O5 = 286.3 | 20mg | QQ客服：1457312923 |
| 落新妇苷; Astilbin | CFN98371 | 29838-67-3 | C21H22O11 = 450.4 | 20mg | QQ客服：2056216494 |
| 漆黄素; Fisetin | CFN98176 | 528-48-3 | C15H10O6 = 286.24 | 20mg | QQ客服：1457312923 |
| 牡荆素-2''-O-鼠李糖苷; Vitexin-2''-O-rhamnoside | CFN98177 | 64820-99-1 | C27H30O14 = 578.52 | 20mg | QQ客服：2159513211 |
| 刺槐素; Robinin | CFN98375 | 301-19-9 | C33H40O19 = 740.7 | 5mg | QQ客服：1457312923 |
| 杨梅酮 4'-甲醚-3-O-鼠李糖苷; Mearnsitrin | CFN98387 | 30484-88-9 | C22H22O12 = 478.4 | 5mg | QQ客服：1457312923 |
| 5,7,3'-三羟基-6,4',5'-三甲氧基黄烷酮; 5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavanone | CFN98393 | 310888-07-4 | C18H18O8 = 362.3 | 5mg | QQ客服：2159513211 |
| 4',5-二羟基-7-甲氧基-6,8-二甲基黄酮; Sideroxylin | CFN98394 | 3122-87-0 | C18H16O5 = 312.3 | 5mg | QQ客服：2056216494 |
| 桉树素; Eucalyptin | CFN98395 | 3122-88-1 | C19H18O5 = 326.4 | 5mg | QQ客服：2056216494 |
| 异补骨脂黄酮; Isobavachin | CFN98400 | 31524-62-6 | C20H20O4 = 324.4 | 20mg | QQ客服：3257982914 |
| 5,7-二羟基-6,8-二甲氧基黄酮; 6-Methoxywogonin | CFN98403 | 3162-45-6 | C17H14O6 = 314.3 | 5mg | QQ客服：2159513211 |
| 橙皮素7-O-葡萄糖苷; Hesperetin 7-O-glucoside | CFN98405 | 31712-49-9 | C22H24O11 = 464.4 | 10mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)